Global Basal Cell Skin Cancer Treatment Market Quantitative Analysis: Market Scale is $1416.29 million in 2024

Global Basal Cell Skin Cancer Treatment Market Overview

According to Global Market Monitor, the global basal cell skin cancer treatment market size is $1416.29 million in 2024 and is expected to hit $2302.74 million by 2029.

Basal cell carcinoma (BCC) is the most common form of skin cancer and the most frequently occurring form of all cancers. BCCs arise from abnormal, uncontrolled growth of basal cells. Because BCCs grow slowly, most are curable and cause minimal damage when caught and treated early.

The Increase in Basal Cell Carcinoma

Basal cell carcinoma is the most common type of non-melanoma skin cancer and is generally referred to as a ‘rodent ulcer’. Skin has three main types of cells in the top layer of the skin in which basal cells line the epidermis layers. Basal cells are shed or replaced as new ones grow/form. Basal cell carcinoma develops when DNA is damaged from exposure to UV radiation from the sun due to this tanning triggers the changes in basal cells of the outermost layers of the epidermis and uncontrolled cell growth. The carcinoma looks like open sores, red patches, shiny bumps, and slightly elevated growth on the skin with rolled edges.

Basal cell carcinoma affects slightly more men than women. It occurs more often in older people. People with fair skin and light eyes are more likely to get BCC. It is 19 times more common in whites than blacks, but people of color may still be affected. People who have had BCC once are at higher risk for developing another lesion.

Basic cell carcinoma is usually easy to detect and has an excellent record of successful treatment, although it may recur in some cases. Early diagnosis and treatment can reduce the risk of recurrence and metastasis. Global basal cell carcinoma and the increase in the elderly are important factors to promote the growth of this market.

Market Restraints

Lack of patient awareness may hinder the global basal cell cancer treatment market. Basal cell carcinoma is the malignant tumor with the highest incidence of skin cancer, which is easy to occur in middle-aged and elderly people. 70%~90% of basal cell cancers occur in the forehead, cheeks nose, etc. Cancer cells grow slowly, showing local invasion and destruction, and rarely metastasize. At first, the nodules with small wax-like luster are gradually enlarged, and an ulcer is formed in the middle, which is ignored by people because it is painless.

In addition, misdiagnosis and missed diagnosis are also some of the main factors that hinder the development of the market. BCC is usually localized skin cancer. It is important to make a correct diagnosis, because misdiagnosing one skin cancer as another may lead to the wrong treatment or delay the effective treatment. Missed BCC (false negative result) will lead to the spread or even disfigurement of cancer cells. If you are diagnosed with skin cancer without cancer (i.e. false positive result), it may bring unnecessary biopsy or treatment and may bring pain and anxiety to the patient.

Drivers	The increase in basal cell carcinoma.
	The rise of research and investment in the basic cell cancer market.
Restraints	Lack of Patient Awareness
	Misdiagnosis and Missed Diagnosis

For more industry information, please refer to our latest released "2023 Global Treatment of basal cell skin cancer Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".